A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease

Mark A. Schroeder, H. Jean Khoury, Madan Jagasia, Haris Ali, Gary J. Schiller, Karl Staser, Jaebok Choi, Leah Gehrs, Michael C. Arbushites, Ying Yan, Peter Langmuir, Nithya Srinivas, Michael Pratta, Miguel Angel Perales, Yi Bin Chen, Gabrielle Meyers, John F. DiPersio

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint Dive into the research topics of 'A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease'. Together they form a unique fingerprint.

Medicine & Life Sciences